Neuro · Movement Disorder

Parkinson Disease

TRAP. Pillrolling tremor at rest. A dying patch of substantia nigra that took the dopamine with it. Levodopa walks the patient back from the cliff. Lewy bodies are the receipt.

TRAP Substantia Nigra Lewy Bodies Levodopa

Opening case · 67 yo Man

A 67-year-old retired carpenter is brought in by his daughter. Over the past nine months his right hand has been rolling pills when it rests in his lap, but the shaking quiets the moment he reaches for a coffee cup. On exam, his right wrist gives a ratchety, cogwheel resistance when you bend it. His face is flat. He takes small, shuffling steps and barely swings his right arm.

What is the single best diagnosis?

Lock it in: Parkinson disease. The cluster is asymmetric rest tremor that vanishes with action, cogwheel rigidity, masked facies, and a shuffling gait with decreased arm swing. That is TRAP, with the asymmetric onset that screams idiopathic Parkinson over every imitator. Essential tremor shakes when the hand is doing something, not when it rests. Huntington brings chorea and a strong family history, not a flat face. Wilson hits in the twenties with a Kayser-Fleischer ring. Drug-induced parkinsonism mimics this picture but appears symmetrically within weeks of starting a dopamine-blocking drug, and our carpenter is on none.

The Clues

Four ways the stem hands it to you

Any one of these in a vignette is enough. Two of them is the answer. Stop reading at the second clue and pick Parkinson.

Clue 01

TRAP cluster

Tremor at rest, Rigidity (cogwheel), Akinesia or bradykinesia, Postural instability with shuffling gait. Three of the four is the floor for a clinical diagnosis.

Clue 02

Pillrolling at rest

A 4 to 6 Hz thumb-against-finger tremor that shows up when the hand sits still and improves the second the patient grabs for something. Asymmetric. Worse on one side first.

Clue 03

Lewy bodies on path

Round, eosinophilic, cytoplasmic inclusions of aggregated alpha-synuclein inside surviving neurons of the substantia nigra. Pathognomonic for idiopathic Parkinson.

Clue 04

Levodopa walks them back

The motor signs improve dramatically on levodopa. If a patient's symptoms do not budge on a real dose, the diagnosis was probably not Parkinson to begin with.

The Mnemonic

TRAP, one letter at a time

Tap each letter. The cluster locks in faster when you say it out loud.

T · Tremor at rest

Pillrolling, 4 to 6 Hz, asymmetric, present when the limb is supported and at rest. Quiets the second the patient reaches for something. Goes away in sleep. Stem giveaway: "rolling a pill between thumb and index finger" or "tremor disappears when she reaches for the cup."

The Anatomy

Substantia nigra, healthy vs dying

Axial cross-section through the midbrain at the level of the superior colliculi. Toggle the state.

Healthy. The substantia nigra pars compacta is jet black on a fresh midbrain section because its dopaminergic neurons are packed with neuromelanin. Two crescent strips sit on top of the cerebral peduncles, projecting forward into the striatum.

The Pathology

Lewy body, photo and schematic

Real H&E on the left so you know what it looks like under the scope. Schematic on the right so you know what is happening inside.

Real photo · H&E

Lewy body in the substantia nigra, H&E stain

Substantia nigra neuron with a round, eosinophilic Lewy body in the cytoplasm. Public domain · Wikimedia Commons.

Schematic · idealized

What you are looking at: aggregated alpha-synuclein clumps in the cytoplasm of a surviving substantia nigra neuron. On H&E it reads as a round, pink, eosinophilic ball with a pale halo, sitting beside a pushed-aside nucleus. Idiopathic Parkinson disease cannot leave without depositing one of these.

The synucleinopathies family: alpha-synuclein is THE protein that links three diseases. Parkinson disease (Lewy bodies in substantia nigra), Lewy body dementia (Lewy bodies in cortex too, which is why the cognitive piece arrives early), and multiple system atrophy (alpha-synuclein in glial cells instead of neurons, with early autonomic failure). Same protein, different real estate, three different clinical pictures.

The Cascade

Alpha-synuclein, monomer to Lewy body

Five stages from a normal folded protein to the toxic inclusion that kills the neuron. Tap a stage.

Monomer. The native folded form. Alpha-synuclein normally lives at the presynaptic terminal of healthy neurons, where it helps recycle synaptic vesicles. In this state it is harmless. Then a hit (genetics, oxidative stress, a misfolding seed) flips one molecule into a wrong shape, and the cascade begins. Why it matters: the protein that becomes the Lewy body starts as a normal, useful piece of the synapse. Parkinson is what happens when housekeeping breaks.

The Gait

Upright vs stooped, side by side

Two figures, same scale. The Parkinson silhouette is what a clinician sees walking down the hallway.

Normal

Head over hips, trunk upright
Arms swing through full stride, opposite to leg
Heel strike with regular step length
Smooth turn on a single pivot

Parkinson

Stooped trunk, head pulled forward
Arms flexed at elbows, decreased or absent arm swing
Small shuffling steps, festinating (speeding up)
Turns in many tiny steps (en bloc), retropulsion on pull test

The Treatment

Treatment ladder

Climb from the cleanest motor win to the heavier hardware. Tap a rung.

Levodopa
crosses BBB

Brain converts it
to dopamine

Carbidopa
blocks peripheral conversion

Why it works Dopamine cannot cross. Levodopa can.

Send the precursor across the BBB, then let the brain finish the synthesis.

Why add carbidopa Keeps levodopa out of the gut/blood leak.

Less nausea, vomiting, orthostasis, arrhythmia. More dose reaches brain.

Long-term trap On-off swings + dyskinesias.

Later: anxiety, agitation, and visual hallucinations as the window narrows.

Pearl: if a patient with suspected Parkinson does not improve on an adequate levodopa trial, reconsider the diagnosis. Atypical parkinsonism barely budges.

Examples Pramipexole, ropinirole, rotigotine

Directly stimulate striatal D2 receptors.

Best niche Younger patient, under 65

Delay cumulative levodopa exposure when symptoms allow it.

Board trap Impulse-control behavior

Gambling, hypersexuality, binge eating, sleep attacks.

Pearl: the impulse-control side effect is the discriminator in clinical questions; a Parkinson patient with new compulsive gambling on a new drug is almost always on a dopamine agonist.

Examples Selegiline, rasagiline, safinamide

Block MAO-B in the brain synapse.

Use Early mild disease or wearing-off add-on

Leftover dopamine lingers longer between doses.

Side note Selegiline can cause insomnia

Partly metabolized to amphetamine-like compounds.

Pearl: combining any MAO-B inhibitor with an SSRI, SNRI, or meperidine risks serotonin syndrome. Screen the med list.

Examples Entacapone, opicapone, tolcapone

CAPONE cue = COMT blocker.

Use Add-on only

Extends levodopa. Does nothing without levodopa on board.

Trap Tolcapone = liver checks

Rare fatal hepatotoxicity. Entacapone is the standard pick.

Pearl: COMT inhibitors smooth out end-of-dose wearing-off. They do not work without levodopa already on board.

Main use Levodopa-induced dyskinesias

NMDA antagonism cools involuntary movements.

Also Mild anti-Parkinson effect

Modest symptomatic help, not a core long-term anchor.

Side effects Livedo reticularis

Also ankle edema and hallucinations in older patients.

Pearl: if a board stem mentions livedo reticularis in a Parkinson patient, the drug is amantadine.

Examples Benztropine, trihexyphenidyl

Block muscarinic tone in the striatum.

Best for Tremor-dominant younger patient

Weak for bradykinesia and rigidity.

Avoid Older or cognitively fragile

Confusion, urinary retention, constipation, dry mouth, falls.

Pearl: the niche is a younger Parkinson patient whose dominant complaint is tremor. Old patient with mild cognitive impairment? Stay away.

Targets STN or GPi

Electrodes disrupt abnormal basal-ganglia output.

Candidate Still levodopa responsive

Disabling fluctuations despite optimized medical therapy.

Do not use Poor levodopa response

DBS cannot create a response levodopa never showed.

Pearl: DBS improves the same symptoms that levodopa improves. If levodopa never helped, DBS will not either.

The Game

Dopamine rescue switchboard

Parkinson pharm is not a list. It is a rescue run: stop the leak, cross the gate, stretch the dose, punish the side effect, then earn the hardware.

Station 1 of 7

Gut leak

Score 0/7

Drug Class · Deeper Cut

Dopamine agonists, the parallel option

Bypass the dying neurons. Hit the receptor directly. Used for Parkinson AND restless leg syndrome, with a trap built into long-term use.

Class · D2 receptor agonist Direct stim

Pramipexole Oral · first-line in younger PD and RLS

Ropinirole Oral · PD and RLS, similar profile

Rotigotine Patch · transdermal 24-hour delivery

Bromocriptine Older ergot derivative

Cabergoline Long-acting ergot derivative

Apomorphine Subcutaneous rescue for off episodes

D2 signal Direct D2 stimulation

No dying substantia nigra neuron required. The receptor gets the signal directly.

Pick them when Younger PD or restless legs

Delay levodopa exposure in patients under 65 when symptoms allow it.

Red flag New compulsions

Gambling, hypersexuality, binge eating, sleep attacks, edema, hallucinations.

RLS augmentation Earlier, stronger symptoms that spread beyond the legs.

That means the dopamine agonist is worsening the disease pattern. Switch to gabapentin or pregabalin.

Pearl: a Parkinson or RLS patient who started a new dopamine agonist and developed compulsive gambling on top of it is not a coincidence. The drug is doing it. Reduce the dose or switch class. See restless leg syndrome >

Drug Class · Deeper Cut

COMT inhibitors, the levodopa extender

Block the second peripheral leak. More levodopa to brain, longer dose half-life, smoother motor day.

Class · COMT inhibitor "Al CAPONE COMiT crimes"

Entacapone Standard pick · given with each levodopa dose

Tolcapone Reserved · rare fatal hepatotoxicity, monitor LFTs

Opicapone Once-daily dosing add-on

"Capone" cue enta-CAPONE, tol-CAPONE = COMT

Levodopa dose

COMT would methylate it

COMT inhibitor
keeps more available

Normal COMT Breaks down catecholamines

Periphery: levodopa to 3-O-methyldopa. Synapse: dopamine clearance.

Inhibitor effect Smoother dose curve

More levodopa reaches brain, fewer wearing-off troughs.

Use rule Add-on only

No levodopa on board means COMT blockade has nothing useful to extend.

Al CAPONE COMiT crimes Orange urine is harmless Tolcapone needs LFTs

Pearl: COMT inhibitors smooth out wearing-off, they do not work as monotherapy. Tolcapone is the one to memorize for rare fatal hepatotoxicity (LFT monitoring required); entacapone is the safe everyday pick.

The Circuit

Direct vs indirect pathway

Two basal ganglia loops, opposite jobs, both run on dopamine. Toggle healthy vs Parkinson to see why movement collapses.

Direct · D1 · "GO"

Cortex fires the striatum. The striatum (GABA) inhibits the GPi. GPi normally brakes the thalamus, so quieting GPi releases the thalamus, which fires the cortex back. Net: more movement.

Indirect · D2 · "STOP"

Cortex fires the striatum, which inhibits the GPe. With the GPe quieted, the STN is unleashed (glutamate) and drives GPi harder. GPi brakes the thalamus more. Net: less movement.

Healthy. Substantia nigra dopamine stimulates D1 (turns the direct GO pathway up) and blocks D2 (turns the indirect STOP pathway down). Both pushes net to more movement. The two loops stay balanced, the patient walks normally.

The Hardware

Deep brain stimulation (DBS)

Electrodes into the basal ganglia. For patients who still respond to levodopa but have stopped getting smooth days from it.

Consider when Fluctuations or dyskinesias persist

Medical therapy is optimized but the day is still on-off.

Must have Clear levodopa response

That proves the diagnosis and predicts DBS benefit.

Does not do Cure or stop progression

It smooths swings and can lower the levodopa dose.

Rule of thumb: DBS improves the symptoms levodopa already improves. If levodopa never helped, DBS will not either.

The Fork

Tremor at the bedside, three forks

Commit to an answer before the reveal opens. Each fork narrows the lineup the way you would at the bedside.

A 68-year-old arrives with a hand tremor. You have not touched the patient yet. Work the tree one fork at a time and choose before you tap open the reasoning.

Fork 1 · When is the tremor worst?

Rest = ParkinsonAction = essential tremorMovement quiets PD tremor

Move: a tremor that backs off when the hand reaches for a cup is Parkinson until proven otherwise.

Fork 2 · One side or both?

Asymmetric first = idiopathic PDSymmetric early = atypical/drugFalls/autonomic early = red flag

Move: one-sided onset keeps Parkinson in front; symmetric day-one disease reopens the differential.

Fork 3 · You add carbidopa-levodopa. What happens?

Levodopa works = PDLevodopa fails = atypicalDBS predicts from levodopa

Move: strong levodopa response seals the diagnosis and predicts DBS benefit.

The Lineup

Parkinson versus its imitators

Five faces that all walk into the room looking parkinsonian. Tap a tab for the one tell that separates each from idiopathic disease.

Essential tremor

PatternBilateral action tremor

Shows up holding a glass or signing.

Extra cluesFamily history, alcohol helps

No rigidity, no bradykinesia, normal arm swing.

TreatPropranolol or primidone

Not levodopa.

The one tell: tremor on action and bilateral from the start, the mirror image of the Parkinson rest tremor.

Progressive supranuclear palsy

PatternSymmetric parkinsonism

Early backward falls and axial rigidity.

Eye clueVertical gaze palsy

Cannot look down.

Drug responsePoor levodopa response

Tau disease downstream of dopamine.

The one tell: vertical gaze palsy plus early falls. Parkinson keeps its eye movements and falls late.

Multiple system atrophy

PatternEarly autonomic failure

Orthostasis, urinary retention, erectile dysfunction.

Variant clueCerebellar ataxia

MSA-C adds imbalance and coordination signs.

MRI/drugHot cross bun, poor levodopa

Pontine sign plus weak response.

The one tell: autonomic collapse out of proportion to the motor signs. Parkinson's autonomic trouble is mild and late.

Drug-induced parkinsonism

PatternSymmetric rigidity/bradykinesia

Both sides together, not one hand first.

TriggerD2-blocking drug

Antipsychotics or metoclopramide within weeks.

FixStop the offending drug

No Lewy bodies, no nigral cell loss.

The one tell: a culprit drug plus symmetric onset. Parkinson is asymmetric and not tied to a new prescription.

Wilson disease

PatientUnder 40 + liver disease

Behavioral change or dysarthria can ride along.

TremorWing-beating proximal tremor

Not the tiny pillrolling rest tremor.

Confirm/treatKF ring, low ceruloplasmin

High urinary copper. Chelation plus zinc.

The one tell: young age plus hepatitis plus a copper ring. Parkinson is a disease of the 60s with no liver story.

Under The Scope

What it actually looks like

The gross brain, the histology, and the bedside posture. Tap any image to enlarge.

Histological section of the substantia nigra in Parkinson disease showing depigmentation and neuronal loss — **Substantia nigra histology.** Loss of neuromelanin-rich dopaminergic neurons in the pars compacta. Public domain · Wikimedia Commons.

Medical illustration of Parkinson disease showing the substantia nigra and dopamine pathway to the striatum — **The dopamine pathway.** Nigrostriatal projection from the substantia nigra to the basal ganglia that dies back in Parkinson. CC BY · Wikimedia Commons.

Historical clinical photograph of a man with Parkinson disease showing the stooped flexed parkinsonian posture — **The parkinsonian posture.** Stooped, flexed stance with the arms held close, the bedside silhouette of advanced disease. Public domain · Wikimedia Commons.

The Hooks

Five things that stick

Short handles for the traps the stem leans on.

Hook 01

TRAP at rest

Tremor, Rigidity, Akinesia, Postural instability. The tremor is the one that quiets when the hand starts moving. Action tremor is the imitator.

Hook 02

Carbidopa rides the bus

Carbidopa cannot cross into the brain. It guards levodopa in the periphery so the dose survives the trip, cutting nausea and dropping the total levodopa needed.

Hook 03

CAPONE blocks COMT

Entacapone and tolcapone block COMT. Orange urine is harmless. Tolcapone is the one that needs liver enzyme checks for rare hepatotoxicity.

Hook 04

One protein, three addresses

Alpha-synuclein in nigral neurons is Parkinson, in cortical neurons is Lewy body dementia, in glial cells is multiple system atrophy. Same culprit, different zip code.

Hook 05

DBS only copies levodopa

Stimulate the STN for the full motor win, the GPi when dyskinesia or mood drives the choice. DBS improves only what levodopa already improved.

Test Yourself

Ten vignettes, all original

No question is lifted from any qbank. Pure board logic, written for this page.

Ten questions. Read the stem, tap your pick. Each wrong choice gets its own elimination rule so you walk away smarter than you came.

Keep Going

Continue studying

Parkinson lives in the neuro block. Walk to the rooms next door.

Next door

Movement disorders

The full lineup: chorea, dystonia, myoclonus, tremor. Where Parkinson sits in the bigger map.

Next door

Lenticulostriate strokes

The other way the basal ganglia get hit. Lacunes, the internal capsule, and pure motor signs.

Next door

Seizures

Stay in neuro. Classify the seizure, then reason to the first-line drug from the mechanism.

Medically reviewed by Kaitlyn Cocuzzo, MD and Fatima Ali, DO · Last updated July 1, 2026 at 10:03 PM ET

Bone Wizardry is an independent educational resource for visual learning in the medical sciences. It is not affiliated with, endorsed by, or sponsored by any licensing or examination board, contains no real or recalled examination questions, and does not guarantee any educational or examination outcome.